CCTC Transplant Financial Coordination and Insurance Authorization

Question 1

The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (effective January 2023) changed Medicare Part B coverage of immunosuppressants for ESRD-based Medicare beneficiaries in what significant way?

Accepted Answer

Extended coverage to the lifetime of the functioning graft, eliminating the prior 36-month coverage cliff

Answer

Extended coverage from 12 months to 36 months post-transplant

Answer

Transferred immunosuppressant coverage from Part B to Part D for all transplant recipients

Answer

Required co-insurance to be capped at $35/month for immunosuppressants

Question 2

A transplant candidate's commercial insurer denies prior authorization for the transplant evaluation, citing 'lack of medical necessity.' What is the transplant coordinator's most appropriate FIRST step?

Accepted Answer

Facilitate a peer-to-peer review between the transplant physician and the insurer's medical director

Answer

Advise the patient to self-pay for the evaluation and seek reimbursement later

Answer

Immediately file a formal complaint with the state insurance commissioner

Answer

Refer the patient to a transplant center that is in-network with the insurer

Question 3

A post-transplant kidney patient cannot afford their tacrolimus and mycophenolate prescriptions and has no insurance. Which resource should the transplant coordinator PRIMARILY direct this patient to for medication assistance?

Accepted Answer

Pharmaceutical manufacturer Patient Assistance Programs (PAPs)

Answer

The UNOS emergency transplant drug fund

Answer

The CMS Transplant Quality Incentive Payment Program

Answer

Medicare Part A hospital coverage for outpatient prescriptions

Question 4

Under CMS Conditions of Participation (CoPs) for transplant centers, which financial disclosure is explicitly required as part of the transplant evaluation and listing process?

Accepted Answer

Information about estimated transplant costs and available financial assistance resources provided to the candidate

Answer

A guaranteed maximum price contract signed before listing

Answer

Proof of financial solvency covering at least 5 years of post-transplant costs

Answer

Mandatory enrollment in supplemental insurance before the candidate can be listed

Question 5

A kidney transplant recipient who qualified for Medicare solely through ESRD loses their job and is concerned about insurance coverage 20 months post-transplant. Which coverage options should the transplant coordinator help the patient simultaneously explore?

Accepted Answer

All available options concurrently: COBRA, Medicaid, Medicare ESRD (if applicable), and ACA marketplace plans with special enrollment

Answer

COBRA continuation coverage only, as it is the fastest option

Answer

Medicaid only, as the patient has no income

Answer

Medicare ESRD reinstatement only, as it provides the most comprehensive transplant coverage

Question 6

A patient considering multi-listing at two transplant centers in different UNOS regions to reduce wait time asks the coordinator about the financial implications. Which statement is most accurate?

Accepted Answer

Multi-listing is legal and may reduce wait time, but patients bear costs at each center — duplicate evaluations, labs, and travel — with variable insurance coverage

Answer

Multi-listing is federally prohibited and exposes the patient to financial penalties

Answer

UNOS provides a financial subsidy specifically to support multi-listed patients' travel costs

Answer

Insurance is federally required to cover all evaluation and maintenance costs at each listed center equally